Villere ST Denis J & Co. LLC Cuts Stock Holdings in Kenvue Inc. $KVUE

Villere ST Denis J & Co. LLC lessened its stake in Kenvue Inc. (NYSE:KVUE) by 5.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 743,138 shares of the company’s stock after selling 43,000 shares during the quarter. Villere ST Denis J & Co. LLC’s holdings in Kenvue were worth $12,812,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in KVUE. Oak Thistle LLC acquired a new stake in Kenvue in the 4th quarter valued at $1,563,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Kenvue by 25.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after purchasing an additional 84,219 shares in the last quarter. SG Americas Securities LLC lifted its stake in shares of Kenvue by 3,889.9% during the fourth quarter. SG Americas Securities LLC now owns 3,075,723 shares of the company’s stock worth $53,056,000 after purchasing an additional 2,998,635 shares in the last quarter. Moors & Cabot Inc. boosted its position in shares of Kenvue by 66.9% in the third quarter. Moors & Cabot Inc. now owns 313,122 shares of the company’s stock worth $5,082,000 after buying an additional 125,517 shares during the period. Finally, Cohen Capital Management Inc. acquired a new stake in shares of Kenvue in the fourth quarter valued at about $2,448,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.59% of the stock is owned by insiders.

Analyst Ratings Changes

Several brokerages recently commented on KVUE. Citigroup dropped their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Barclays lowered their price objective on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. UBS Group decreased their price objective on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. Finally, Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Three investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Stock Up 1.6%

KVUE traded up $0.32 during trading on Friday, hitting $19.50. The company had a trading volume of 9,451,469 shares, compared to its average volume of 18,740,484. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The company has a market cap of $37.43 billion, a PE ratio of 22.94, a P/E/G ratio of 1.46 and a beta of 0.47. The business has a 50-day moving average of $18.06 and a 200-day moving average of $17.79.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $0.24 EPS. As a group, analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.3%. Kenvue’s dividend payout ratio is presently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.